Opus Genetics’ VEGA-3 Trial Hits Primary Endpoint for Phentolamine 0.75% for Presbyopia
Phentolamine 0.75% improved near vision at 12 hours post-dose on Day 8. Opus Genetics (North Carolina, United States) has announced…
Amneal Gets FDA Green Light for Prednisolone Acetate Ophthalmic Suspension
A new option enters the American market for treating ocular inflammation. Amneal Pharmaceuticals (New Jersey, United States) announced on Thursday…
popular posts
latest posts
